Products
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$149/mo
Higher than 89% of peersNiche median $29/mo
Creators
Steve Otto
No social account linked
Launched
24mo ago
2024-12-04 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Turning website browsers into buyers

    Dec 4, 2024 · 24mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2019-11-14

KeywordMonthly volume
utm campaign slugs320
mightyrep30

Traffic data: Vaneform

Pricing

Starter (Pay-as-you-go)
$149/mo
15 contacts
Pro (Subscription)
$625/mo
500 contacts
Enterprise (Annual Contract)
$1,000/yr (billed annually)
1,000+ contacts

Trial: 30 days free—no commitment required. · 3 paid tiers ($149–$1000) · Observed 2026-11-08 · Pricing page

Entry price $149/mo, Higher than 89% of peers; “Lead Databases & Enrichment” median is $29/mo.View pricing benchmark

Website snapshots

Indexed 2024-12-04

Key pages

Desktop & mobile archive
mightyrep.com/ Snapshot 2026-11-09

Questions & evidence

How much does MightyRep cost?
Starter (Pay-as-you-go): $149/mo; Pro (Subscription): $625/mo; Enterprise (Annual Contract): $1,000/yr (billed annually). Observed 2026-11-08. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does MightyRep get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is MightyRep and what platforms does it support?
MightyRep is catalogued under Lead Databases & Enrichment: Stop Paying for Leads You Can’t Use! Supported platforms: Web.

Related products in this category

Sales / Lead Databases & Enrichment

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.